1. Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer. Issue 1 (January 2019) Authors: Horita, Yosuke; Nishino, Michiko; Sugimoto, Saiho; Kida, Akihiko; Mizukami, Atsuyoshi; Yano, Masaaki; Arihara, Fumitaka; Matsuda, Koichiro; Matsuda, Mitsuru; Sakai, Akito Journal: Anti-cancer drugs Issue: Volume 30:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗